U.S. market Closed. Opens in 11 hours 37 minutes

SNPX | Synaptogenix, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue6.35K5.71K4.97K4.87K4.38K
Gross Profit-6.35K-5.71K-4.97K-4.87K-4.38K
Operating Expenses8.31M16.13M12.62M11.16M15.51M
Selling, General & Admin6.33M9.81M8.28M8.09M9.84M
Research & Development1.97M6.32M4.34M3.07M5.67M
Other Operating ExpensesN/AN/AN/A28.36KN/A
Operating Income-8.31M-26.36M-12.62M-9.46M-15.51M
Other Expenses / Income2.28M20.79M7.11K-3.25M378.71K
Before Tax Income-6.04M-5.57M-12.61M-12.70M-15.13M
Income Tax Expenses7.74M-115.89K-7.11K1.55M-378.71K
Net Income-6.04M-5.46M-12.60M-14.25M-14.76M
Interest ExpensesN/A-20.67MN/AN/AN/A
Basic Shares Outstanding466.08K6.99M5.02M1.26M5.95M
Diluted Shares Outstanding466.08K6.99M5.02M1.26M5.95M
EBITDA-8.31M-26.36M-12.61M-9.45M-15.51M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT1.70M-26.25M-12.61M-12.70M-15.13M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙